{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Hexamethylene_Bisacetamide",
  "nciThesaurus": {
    "casRegistry": "3073-59-4",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "A hybrid polar-planar compound with potential antineoplastic activity that induces terminal differentiation, inhibits cell growth, and causes apoptosis in several tumor cell lines.  Its precise mechanism of action is unknown.",
    "fdaUniiCode": "LA133J59VU",
    "identifier": "C1125",
    "preferredName": "Hexamethylene Bisacetamide",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C1934",
      "C292"
    ],
    "synonyms": [
      "Acetamide, N,N'-1, 6-hexanediylbis-",
      "Acetamide, N,N'-hexamethylenebis-",
      "HEXAMETHYLENE BISACETAMIDE",
      "HMBA",
      "Hexamethylene Bisacetamide",
      "Hexamethylene bisacetamide",
      "Hexamethylenebisacetamide",
      "Hexamethylenediacetamide",
      "N, N'-Diacetylhexamethylenediamine",
      "N,N'-1,6-Hexanediylbisacetamide",
      "N,N'-Hexamethylenebisacetamide"
    ]
  }
}